GISAR German Interdisciplinary Sarcoma Registry

GISAR has an open and modular setup. It is sought to include as many German sarcoma and CS patients (i.e. sarcoma and CS patients treated in Germany) in the registry as possible. A basic data set should be collected on every included patient). In order to adress specific scientific questions, additionally detailed data can be collected in defined patient groups (e.g. effectiveness / adverse effects of systemic therapies in defined situations) within the context of sub-project add-on modules. This data collection can be prospective or retrospective depending on the sub-project

NCT Number	NCT04122872
Lead Sponsor	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Conditions	Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone, Carcinosarcoma
Enrollment	9,000 participants
Start Date	2018-11-29
Primary Completion	2038-01 (estimated)
Study Completion	2038-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-05